Thrombosis & Haemostasis, TH,TH Open/X
Dec 3, 2025, 02:33
Cancer Patients․ Bleeding Risk Rises with Anticoagulants + Antiangiogenics ?
Thrombosis and Haemostasis Journal has shared on X:
” Does Anticoagulants with Angiogenesis Inhibitors Increase Bleeding in Cancer ?
In this network meta-analysis, Chen et al. found that adding anticoagulation to high-dose bevacizumab or antiangiogenic TKIs might increase bleeding risk.”
Read more here.
Stay updated with Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 5, 2025, 03:46Sreeni Sivan Pillai: Preventing Thrombophlebitis and Upper Limb DVT in PICC Lines